Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq of glioblastoma stem cells treated by CCR7 inhibitors.

ABSTRACT: RNA-seq of glioblastoma stem cells treated by CCR7 inhibitors.

PROVIDER: PRJNA901973 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR22301800_1.fastq.gz	Fastqsanger.gz
	SRR22301800_2.fastq.gz	Fastqsanger.gz
	SRR22301801_1.fastq.gz	Fastqsanger.gz
	SRR22301801_2.fastq.gz	Fastqsanger.gz
	SRR22301802_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 18

Similar Datasets

RNA-seq of glioblastoma stem cells treated by CCR7 inhibitors.

Project description:RNA-seq of glioblastoma stem cells treated by CCR7 inhibitors.

2023-08-04 | GSE218041 | GEO

RNA-seq of glioblastoma stem cells with shRNA-mediated CCR7 knockdown

Project description:RNA-seq of glioblastoma stem cells with shRNA-mediated CCR7 knockdown

2023-08-04 | GSE218042 | GEO

RNA-seq of glioblastoma stem cells with shRNA-mediated CCR7 knockdown

Project description:RNA-seq of glioblastoma stem cells with shRNA-mediated CCR7 knockdown

| PRJNA901975 | ENA

CCL21/CCR7 axis in regulating glioblastoma stem cell-lymphatic endothelial cell interaction

Project description:CCL21/CCR7 axis in regulating glioblastoma stem cell-lymphatic endothelial cell interaction

| PRJNA901970 | ENA

Response to the combination of farnesyltransferase inhibitors and gamma-secretase inhibitors in glioblastoma stem cells

Project description:Notch-targeted gamma-secretase inhibitors (GSIs) exhibited limited efficacy in glioblastoma patients. We identified that farnesyltransferase inhibitors (FTIs) increased sensitivity to GSIs in glioblastoma stem cells. To interrogate the mechanisms mediating the interaction between these two classes of compounds, we studied the impact on gene expression profiles by the combination of tipifarnib (FTI) and RO4929097 (GSI). We found that this combination treatment significantly suppressed genes implicated cell cycle progression. Real-time PCR validated the activities of tipifarnib to modulate expression of cell cycle regulators. We also showed that RO4929097 sensitized glioblastoma stem cells to compounds targeting some of these cell cycle regulators, such as AURKB and CDK4/6. These results suggest that regulation of cell cycle progression partially mediates the ability of FTIs to sensitize glioblastoma stem cells to GSIs.

2017-10-11 | GSE104783 | GEO

Transcription profiling of human paediatric glioblastoma cells treated with insulin-like growth factor 1 receptor inhibitors

Project description:We have previously determined the insulin-like growth factor 1 receptor (IGF1R) to be amplified and overexpressed in paediatric glioblastoma. In order to probe the efficacy and mechanisms of action of various inhibitors of the receptor, we have carried out expression profiling of paediatric glioblastoma cells treated with 5x IC50 of the compounds PPP and NVP-AEW541 over a 24 hour time-course.

2011-01-08 | E-TABM-889 | biostudies-arrayexpress

Transcriptomic analysis of Glioblastoma Multiform (GBM) neurospheres treated with BMI1 inhibitors.

Project description:Transcriptomic analysis of Glioblastoma Multiform (GBM) neurospheres treated with BMI1 inhibitors.

| PRJNA592841 | ENA

Response to the combination of farnesyltransferase inhibitors and gamma-secretase inhibitors in glioblastoma stem cells

Project description:Response to the combination of farnesyltransferase inhibitors and gamma-secretase inhibitors in glioblastoma stem cells

| PRJNA413807 | ENA

Quantitative phosphoproteome analysis of glioblastoma stem cells

Project description:Glioblastoma is one of the most malignant brain tumors with poor prognosis and their development and progression are known to be driven by glioblastoma stem cells. Although glioblastoma stem cells lose their cancer stemness properties during cultivation in serum-containing medium, little is known about the molecular mechanisms regulating signaling alteration in relation to reduction of stemness. In order to elucidate the global phosphorylation-related signaling events, we performed a SILAC-based quantitative phosphoproteome analysis of serum-induced dynamics in glioblastoma stem cells established from the tumor tissues of the patient. Among a total of 2,876 phosphorylation sites on 1,584 proteins identified in our analysis, 732 phosphorylation sites on 419 proteins were regulated through the alteration of stem cell characteristics.

2016-01-13 | PXD002614 | Pride

Assessment of Rocaglates and Targeted Derivatives as Selective Inhibitors of Glioblastoma Stem Cells

Project description:Assessment of Rocaglates and Targeted Derivatives as Selective Inhibitors of Glioblastoma Stem Cells

| PRJNA1035127 | ENA